Title: Identificación de los cirRNA y lncRNA que regulan la firma de miRNA de respuesta al tratamiento en pacientes con hepatocarcinoma avanzado. Desarrollo de una herramienta experimental
Funding Entity: Instituto de Salud Carlos III (PI22/00857)
Duration: 2023-2025
Principal Investigator: Jordi Muntané Relat
Granted: 147.317,50 Euros
Title: Converting molecular profiles of myeloid cells into biomarkers for inflammation and cancer (Mye-InfoBank)
Funding Entity: EU Framework Programme-Horizon 2020 (COST Action CA20117)
Duration: 2021-2024
Principal Investigator: Sven Brandau
Management Committee: Jordi Muntané Relat y Concepción Marañón Lizana
Working group: WG 2 Mye-SOP y WG 3 Mye-Disease
Granted: 580.000 Euros
Title: Bench to bedside transition for pharmacologicalregulation diseasesregulation of NRF2 in noncommunicable diseases (BenBedPhar)
Funding Entity: EU Framework Program-Horizon 2020 (COST Action CA20121)
Duration: 2021-2024
Principal Investigator: Antonio Cuadrado
Management Committee (Spain): Manuela García López y Ana Isabel Rojo
Working groups: WG2 Pharmacological regulation and drugs and WP3 Translation medicine
Granted: 580.000 Euros
Title: Aislamiento y criopreservación de hepatocitos humanos útiles para la validación de la actividad de los inhibidores de tirosina quinasa en el metabolismo celular y en los mecanismos de supervivencia y muerte celular
Financial Entity: Consejería de Salud y Familias, Convocatoria Proyectos de investigación e innovación colaboración público-privada (PIP-0215-2020)
Duration: 2021-2023
Principal investigator: Miguel Ángel Gómez Bravo
Granted: 243.788,50 Euros
Title: Identificación del papel de miRNA y lncRNA en las células tumorales circulantes en la progresión y respuesta al tratamiento en pacientes con carcinoma hepatocelular en estadio intermedio y avanzado. Desarrollo de una nueva terapia experimental
Financial Entity: Consejería de Salud y Familias, Convocatoria Proyectos de investigación en salud (PI-0216-2020)
Duration: 2021-2023
Principal Investigator: Jordi Muntané Relat, María Teresa Ferrer Ríos
Granted: 149.508,05 Euros
Title: Functional impact of epigenetic regulation in hepatocarcinoma: Development of combined nanovectorization of miRNAs/lncRNAs and drugs useful in experimental liver cancer model
Financial Entity: Instituto de Salud Carlos III (PI19/01266)
Duration: 2020-2022
Principal Investigator: Jordi Muntané Relat
Granted: 165.770,00 Euros
Title: Biología y Medicina Redox
Financial Entity: Convocatoria 2018 ‐ Acciones de dinamización «Redes de Investigación» (RED2018‐102576‐T)
Duration: 2020-2021
Principal Investigator: Juan Sastre Belloch
Granted: 20.500 Euros
Title: Liquid Biopsy applied to the search for cellular and epigenetic markers for the development of diagnostic, prognostic and predictive tests in patients with hepatocarcinoma (PC-0033-2017)
Financial Entity: Consejería de Salud (Junta de Andalucía)
Duration: 2018-2020
Principal Investigator: José Antonio Lorente Acosta
Granted: 66.065,38 Euros
Title: In vitro 3-D total cell guidance and fitness (COST Action CA16119 CellFit)
Financial Entity: COST Action CA16119
Duration: 2017-2021
Principal Investigator: Tiziana Brevini
Working groups: WG1 3-D Cultures and Bioprinting; WG3 Chemobiological cues and Epigenetic controls
Granted: 580.000 Euros
Project Title: Genetic, transcriptomic and proteomic markers related to the evolution of hepatocarcinoma, co-morbidities and response to treatments (PI16/00090)
Financial Entity: Instituto de Salud Carlos III
Duration: 2017-2019
Principal Investigator: Jordi Muntané Relat
Granted: 152.460 Euros
Title: Extracellular vesicle secretion and its relationship with the evolution of hepatocarcinoma, co-morbidities and response to treatments: Clinical and experimental study (PI-0198-2016)
Financial Entity: Consejería de Salud
Duration: 2017-2019
Principal Investigator: Raul González Ojeda
Granted: 57.465,49 Euros
Title: Stratification of patients with hepatocarcinoma based on the detection and genetic and phenotypic analysis of CTCs: relationship with clinical evolution and response to treatment (PC-0522-2016-0043)
Financial Entity: Consejería de Salud
Duration: 2017-2019
Principal Investigator: José María Álamo
Granted: 16.100 Euros
Title: European Network of Multidisciplinary Research and Translation of Autophagy knowledge (TRANSAUTOPHAGY)
Financial Entity: COST Action CA15138
Duration: 2016-2020
Principal Investigator: Caty Casas
Working groups: WG1: Basic Research on Autophagy Molecular Machinery; WG4: Biomedical Research (iv Cancer).
Granted: 560.000 Euros
Project Title: Mitochondrial mapping: Evolution-Age-Gender-Lifestyle-Environment (MITOEAGLE)
Financial Entity: COST Action CA15203)
Duration: 2016-2020
Principal Investigator: Erich Gnaiger
Working groups: TG3.2 Liver and TG4.2 Cultured cells.
Granted: 540.000 Euros